
photon counting sensors that see what matters
stealth silica that digitizes drugs
3D bioprinted human tissues for organ transplants
Pangaea is a hardtech investor We invest in start-up companies leveraging advanced materials, novel chemistries, and biology to make our world better by creating products to tackle tough problems such as:
We quantify impact as part of our due dilligence and assessment process, so we understand the magnitude of the problem and the scalability of the solution By 2030, our portfolio companies will contribute to:
We work closely with our world-leading Strategic Limited Partners who bring diverse market and industry knowledge:























